SoCalBio Mast
SoCalBio Weekly Update
Thanks to SoCalBio Weekly Update Sponsor
Coming in 2011

SoCalBio Presents
SoCalBio Conference on Cloud Computing
Exploring opportunities and challenges of cloud computing in the highly regulated biotech and medical device industries.
Join SoCalBio
 
Join well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth.
Become a Member
Past Weekly Updates
Editor: Ahmed Enany

President & CEO
Southern California 
Biomedical Council
(SoCalBio)
enany@socalbio.org
www.socalbio.org

July 7, 2010


Thanks to Participants in the SoCalBio/Image 2000 Golf Classic on June 28 at Old Ranch Country Club
SoCalBio Golf Tournament
Prominent News Story
Los Angeles County's Biggest Biotechnology Company Gets Acquired by Celgene

Dr Patrick Soon-Shiong, 57, owns 82.4 percent of Abraxis BioScience of Los Angeles.
Prominent Drug Chief to Sell Abraxis BioScience to Celgene for $2.9 Billion: http://www.nytimes.com/2010/07/01/health/01drug.html

A Billionaire's Biotech Deal And Old Drugs Reborn: http://blogs.forbes.com/sciencebiz/2010/06/a-billionaires-biotech-deal-and-old-drugs-reborn/?partner=yahootix

Shot in the Arm for L.A. Charities? Abraxis payout likely fuel for Soon-Shiong philanthropy: http://www.labusinessjournal.com/news/2010/jul/05/shot-arm-l-charities/
Public Policy
Biz Groups Stand Guard Over Tax Breaks

Hundreds of businesses have begun lining up to defend tax breaks under attack by a labor-sponsored initiative that recently qualified for the November ballot. Proposition 24, backed by the state teachers union, would repeal three tax changes that will save business an estimated $1.7 billion a year. State tax regulators estimate that about 120,000 businesses statewide could lose these breaks if the initiative passes.... Read more: http://www.labusinessjournal.com/news/2010/jul/05/business-groups-stand-guard-over-state-tax-breaks/


Access the Web Siter of the Opposition to Proposition 24
Mark Your Calendar

November 4, 2010
(With a CEO Reception & Dinner on November 3)

J W Marriott of L.A. Live

RSVP Now (Free for SoCalBio Members)
SoCalBio Open House PhotoJuly 23, 8:00 AM to 12:30 PM 
SoCalBio Open House
Wilshire Grand Hotel in Downtown Los Angeles
More Information
RSVP Now


Featuring a keynote presentation on the state of the bioscience industry based on the findings of the Ernst & Young's study entitled
 
"Beyond Borders: Global Biotechnology Report 2010"
 
Learn how SoCalBio's Group Purchasing Program can slow your company's burn rate and cut down the cost of doing business; and get detailed insight into how SoCalBio can help your organization succeed.
 
Recent Headline
Grants:
Studies:
CE Mark:
Product Launch:
Collaboration:
Venture Funding:
  • AqueSys, Inc. Closes $35M Series C Round: -- 
AqueSys, Inc., an Irvine-based medical device company that develops, manufactures and distributes proprietary implants for glaucoma, today announced that it has secured $35 million in Series C financing. The round was led by Longitude Capital and Rho Ventures, with participation from existing investors Accuitive Medical Ventures, The Carlyle Group and SV Life Sciences. http://www.prnewswire.com/news-releases/aquesys-inc-closes-35m-series-c-round-97386599.html

Real Estate:
Personnel:
About SoCalBio 
 
SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio